Zimbabwe has declined a significant American health deal valued at $367m (272 million pounds) over five years over the United States' insistence on sensitive information.
The decision was revealed following a internal memorandum from December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".
An official spokesperson has since explained that the US was requesting genetic material for research and commercial purposes while was unwilling to share the resulting advantages from future medical innovations.
"We will now turn to the challenging and unfortunate task of ending our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had provided over $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged continued negotiations to secure a agreement acceptable to both sides so the country's vital HIV treatment initiative can proceed.
Broader Background
This rejection comes after a comparable situation in Kenya, where a high court blocked a related health funding agreement after concerns were raised about the security of Kenyans' medical information.
Since resuming office recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
USAID had overseen aid for the American government, but Trump claimed its spending was "wasteful" and his government was seeking government-to-government agreements to enhance transparency and accountability.
According to reports, 16 African countries have so far signed these new agreements, constituting over $18.3bn of fresh investment.
Specifics of the Rejected Agreement
The funds for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership could have provided extraordinary advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving HIV treatment via US-supported initiatives," Tremont added.
However, official spokesman Nick Mangwana said the arrangement was "unequal".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, without any corresponding guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that provided information," Mangwana explained.
"In essence, our country would supply the raw materials for scientific discovery without any certainty that the end products would be available to our citizens if a new pandemic emerge."
National Interest and International Frameworks
Mangwana further noted that the US's withdrawal from the global health body and its push of bilateral deals were upending frameworks previously set up via the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing scheme created to deal with potential pandemics.
"This framework is intended to ensure that when a nation contributes its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised solely by those with the resources to create them."
These objections over the US deal "must not be interpreted as anti-American sentiment," he added.
"We are open to ongoing dialogue with our American counterparts on how future co-operation could be arranged in a manner that honours the sovereignty and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but urged that talks should continue since a large portion of the country's Aids initiatives depended on external financing.
"If specific concerns arise, including those relating to information security or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," it said.
The halted deal underscores the continuing debate between receiving much-needed foreign assistance and safeguarding national sovereignty in an increasingly data-driven world.